Efficacy and Safety of Radium-223 Dichloride in Symptomatic Castration-resistant Prostate Cancer Patients With or Without Baseline Opioid Use From the Phase 3 ALSYMPCA Trial.
暂无分享,去创建一个
C. Parker | J. Michalski | S. Nilsson | D. Bottomley | O. Sartor | N. Vogelzang | J. O’Sullivan | R. Coleman | Ø. Bruland | M. Seger | S. Finkelstein | Rui Li